Caroline Morbach1, Thomas Buck2,3, Christian Rost4,5, Sebastian Peter4,6, Stephan Günther4,7, Stefan Störk1, Christiane Prettin8, Raimund Erbel2, Georg Ertl1, Christiane E Angermann9. 1. Comprehensive Heart Failure Center, University and Department of Medicine I, Cardiology, University Hospital Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany. 2. Department of Angiology and Cardiology, University Hospital Essen, Essen, Germany. 3. Department of Cardiology, Heart Center Westfalen, Klinikum Westfalen, Dortmund, Germany. 4. Department of Medicine I, University Hospital Würzburg, Würzburg, Germany. 5. Cardiological Practice, Ludwigstr. 29, 97070, Würzburg, Germany. 6. Kitzinger Land Hospital, Kitzingen, Germany. 7. Barmherzige Brüder Hospital, Regensburg, Germany. 8. Clinical Trial Center Leipzig, University of Leipzig, Leipzig, Germany. 9. Comprehensive Heart Failure Center, University and Department of Medicine I, Cardiology, University Hospital Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany. Angermann_c@ukw.de.
Abstract
BACKGROUND:Patients with suspected heart failure (HF) often present first to general practitioners (GPs). Timely and accurate HF diagnosis and reliable prognostic information have remained unmet goals in primary care, where patient evaluation often relies on clinical assessment only. The Handheld-BNP program investigates whether additional use of portable echocardiography (ECHO) and point-of-care determination of B-type natriuretic peptide (BNP) improves the accuracy of HF diagnosis and aids risk prediction in primary care. METHODS AND RESULTS: A research network was established between 2 academic centers, 2 × 6 cardiologists, and 2 × 24 GPs inexperienced with ECHO and BNP. The Training Study investigates the feasibility of implementing GP use and interpretation of ECHO and BNP. After training, competence is assessed using multiple-choice testing (pass mark: > 80% correct diagnoses). In the cluster-randomized four-arm Screening Study, each GP passes in random order through four study arms: clinical assessment (CA), CA + BNP, CA + ECHO, and CA + ECHO + BNP. Cardiologists' diagnoses serve as reference. Primary endpoint is the rate of correct GP diagnoses per study arm. In the Prognostic Follow-Up Study, patients are followed up centrally for 72 months. Forty-four GPs were successfully trained. With 225 ± 34 (75 ± 3) and 233 ± 28 (81 ± 7) min, respectively, total ECHO (BNP) training times were similar between centers I and II. Furthermore, training results did not differ between centers. CONCLUSIONS: Standardized training of limited duration enabled GPs to use ECHO and BNP for HF diagnosis. The Handheld-BNP program will provide robust evaluation of the diagnostic effectiveness and prognostic value of these tools in primary care. TRIAL REGISTRATION: http://www.controlled-trials.com (ISRCTN23325295).
RCT Entities:
BACKGROUND:Patients with suspected heart failure (HF) often present first to general practitioners (GPs). Timely and accurate HF diagnosis and reliable prognostic information have remained unmet goals in primary care, where patient evaluation often relies on clinical assessment only. The Handheld-BNP program investigates whether additional use of portable echocardiography (ECHO) and point-of-care determination of B-type natriuretic peptide (BNP) improves the accuracy of HF diagnosis and aids risk prediction in primary care. METHODS AND RESULTS: A research network was established between 2 academic centers, 2 × 6 cardiologists, and 2 × 24 GPs inexperienced with ECHO and BNP. The Training Study investigates the feasibility of implementing GP use and interpretation of ECHO and BNP. After training, competence is assessed using multiple-choice testing (pass mark: > 80% correct diagnoses). In the cluster-randomized four-arm Screening Study, each GP passes in random order through four study arms: clinical assessment (CA), CA + BNP, CA + ECHO, and CA + ECHO + BNP. Cardiologists' diagnoses serve as reference. Primary endpoint is the rate of correct GP diagnoses per study arm. In the Prognostic Follow-Up Study, patients are followed up centrally for 72 months. Forty-four GPs were successfully trained. With 225 ± 34 (75 ± 3) and 233 ± 28 (81 ± 7) min, respectively, total ECHO (BNP) training times were similar between centers I and II. Furthermore, training results did not differ between centers. CONCLUSIONS: Standardized training of limited duration enabled GPs to use ECHO and BNP for HF diagnosis. The Handheld-BNP program will provide robust evaluation of the diagnostic effectiveness and prognostic value of these tools in primary care. TRIAL REGISTRATION: http://www.controlled-trials.com (ISRCTN23325295).
Authors: K T Spencer; A S Anderson; A Bhargava; A C Bales; M Sorrentino; K Furlong; R M Lang Journal: J Am Coll Cardiol Date: 2001-06-15 Impact factor: 24.094
Authors: Alex Zaphiriou; Stephen Robb; Tarita Murray-Thomas; Gustavo Mendez; Kevin Fox; Theresa McDonagh; Suzanna M C Hardman; Henry J Dargie; Martin R Cowie Journal: Eur J Heart Fail Date: 2005-06 Impact factor: 15.534
Authors: Frans H Rutten; Maarten-Jan M Cramer; Diederick E Grobbee; Alfred P E Sachs; Johannes H Kirkels; Jan-Willem J Lammers; Arno W Hoes Journal: Eur Heart J Date: 2005-04-28 Impact factor: 29.983
Authors: E Burri; K Hochholzer; N Arenja; H Martin-Braschler; L Kaestner; H Gekeler; T Hatziisaak; M Büttiker; A Fräulin; M Potocki; T Breidthardt; T Reichlin; T Socrates; R Twerenbold; C Mueller Journal: J Intern Med Date: 2012-06-12 Impact factor: 8.989
Authors: M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton Journal: Lancet Date: 1997-11-08 Impact factor: 79.321
Authors: Paul Bornemann; Jeremy Johnson; Samuel Tiglao; Amina Moghul; Sheila Swain; Gina Bornemann; Mike Lustik Journal: J Am Board Fam Med Date: 2015 Nov-Dec Impact factor: 2.657
Authors: Clare J Taylor; Andrea K Roalfe; Rachel Iles; Fd Richard Hobbs; P Barton; J Deeks; D McCahon; M R Cowie; G Sutton; R C Davis; J Mant; T McDonagh; L Tait Journal: Br J Gen Pract Date: 2016-12-05 Impact factor: 5.386
Authors: Anna Bauer; Markus Khalil; Monika Lüdemann; Jürgen Bauer; Anoosh Esmaeili; Roberta De-Rosa; Norbert F Voelkel; Hakan Akintuerk; Dietmar Schranz Journal: Clin Res Cardiol Date: 2018-04-16 Impact factor: 5.460